logo

Dova Pharmaceuticals, Inc. (DOVA)



Trade DOVA now with
  Date
  Headline
9/27/2018 7:49:05 AM Dova Pharma And Salix Enter Into Exclusive Co-Promotion Agreement For DOPTELET
8/9/2018 4:12:45 PM Dova Pharmaceuticals Q2 Loss/share $0.70 Vs. Loss $0.32 Year Ago
6/25/2018 7:04:56 AM Nancy Wysenski Joins Dova Pharma’s Board Of Directors
6/4/2018 7:07:04 AM Dova Pharma Announces Publication Of Pivotal Phase 3 Data And Upcoming Congress Presentations For DOPTELET
5/21/2018 1:47:39 PM Dova Pharmaceuticals Announces U.S. FDA Approval Of DOPTELET
3/19/2018 8:10:44 AM Dova Pharma Signs Exclusive Distribution Agreement With Fosun Pharma For Mainland China And Hong Kong
2/22/2018 8:47:52 PM Dova Pharma Prices Public Offering Of 2.5 Mln Shares At $32/Shr For Proceeds Of About $80.0 Mln
1/30/2018 7:02:50 AM Dova Pharma Names Mark Hahn CFO